Abstract:Objective: Storage of ovarian tissue may restore long-term fertility in patients undergoing treatment that irreversibly damages oocytes. Tissue obtained before any treatment avoids chemotherapy-induced genetic abnormality. Our objective was to cryopreserve ovarian tissue, to evaluate the safety and efficacy of the procedure and to attempt to stimulate follicular growth in xenotransplanted thawed ovarian tissue.Design: Patients undergoing chemotherapy and/or radiotherapy were counseled regarding the risk of loss of ovarian function, cryostorage of ovarian cortex, transplantation into an animal host for stimulation, and ethical issues prior to enrollment. Ovarian cortex was cryopreserved, transplanted in immunosuppressed mice and stimulated with gonadotropins. Fresh, frozen and transplanted tissues were histologically evaluated.Materials and methods: Ovarian tissue was surgically removed and collected in PBS containing hFSH. The outer 4 mm of the ovarian cortex was dissected into cubes of 1×1×0.5 mm and frozen in straws or cryovials in Leibovitz medium L-15+10% serum +1.5M ethylene glycol. Fresh and frozen-thawed ovarian cortex was transplanted into nude or NOD-SCID mice, which were stimulated with hFSH.Results: 17 patients (26–39 yrs) were enrolled in this study. 12–100 ovarian fragments/patient were frozen. Follicle count decreased with patient age and a large variability in follicular number was observed between fragments, even in the same patient. Prior therapy did not preclude successful ovarian cryopreservation. The xenotransplantation of tissue from patients with good follicular counts resulted in follicular development and successful retrieval of immature oocytes.Conclusion: Oocyte retrieval from cryopreserved xenotransplanted human ovarian cortex is feasible, enabling evaluation of fertility potential as well as assessment of ovarian cryopreservation safety. Objective: Storage of ovarian tissue may restore long-term fertility in patients undergoing treatment that irreversibly damages oocytes. Tissue obtained before any treatment avoids chemotherapy-induced genetic abnormality. Our objective was to cryopreserve ovarian tissue, to evaluate the safety and efficacy of the procedure and to attempt to stimulate follicular growth in xenotransplanted thawed ovarian tissue. Design: Patients undergoing chemotherapy and/or radiotherapy were counseled regarding the risk of loss of ovarian function, cryostorage of ovarian cortex, transplantation into an animal host for stimulation, and ethical issues prior to enrollment. Ovarian cortex was cryopreserved, transplanted in immunosuppressed mice and stimulated with gonadotropins. Fresh, frozen and transplanted tissues were histologically evaluated. Materials and methods: Ovarian tissue was surgically removed and collected in PBS containing hFSH. The outer 4 mm of the ovarian cortex was dissected into cubes of 1×1×0.5 mm and frozen in straws or cryovials in Leibovitz medium L-15+10% serum +1.5M ethylene glycol. Fresh and frozen-thawed ovarian cortex was transplanted into nude or NOD-SCID mice, which were stimulated with hFSH. Results: 17 patients (26–39 yrs) were enrolled in this study. 12–100 ovarian fragments/patient were frozen. Follicle count decreased with patient age and a large variability in follicular number was observed between fragments, even in the same patient. Prior therapy did not preclude successful ovarian cryopreservation. The xenotransplantation of tissue from patients with good follicular counts resulted in follicular development and successful retrieval of immature oocytes. Conclusion: Oocyte retrieval from cryopreserved xenotransplanted human ovarian cortex is feasible, enabling evaluation of fertility potential as well as assessment of ovarian cryopreservation safety.

[Capability of Oocyte Maturation in Human Cryopreserved Ovarian Tissue Following Xenografting].

The experimental study on the xenograft of frozen-thawed human fetal ovarian tissue

The investigation of xenografted human fetal ovarian tissue

Morphology and Cell Proliferation Evaluation of Follicles from Cryopreserved Human Ovarian Tissue by Vitrifiction and Slow-cooling

[Investigation of Follicular Development and Oocyte Maturation after Cryopreservation and Xenograft of Newborn Mouse Ovaries].

Influencing factors and research progress of the human ovarian tissue xenotransplantation

Research Progress of Human Ovarian Tissue Xenograft Model

The Histological Investigation of Transplantation in Nude-mice of Ovarian Tissue

CAPABILITY OF MATURATION, FERTILIZATION AND FURTHER DEVELOPMENT OF OOCYTES RETRIEVED FROM RABBIT OVARIAN TISSUE TREATED WITH CRYOPRESERVATION AND AUTOLOGOUS TRANSPLANTATION

Improved Developmental Competence and Spindle Assembly of in Vitro Maturation of Human Oocytes by Prolonged Culture Duration

Offspring from Oocytes Grown in Frozen-Thawed Ovarian Tissues Transplanted to Male and Female Bodies

Offspring from Heterotopic Transplantation of Newborn Mice Ovaries.

Developmental Potential of Oocytes Fertilized by Conventional in Vitro Fertilization (IVF) or Intracytoplasmic Sperm Injection (ICSI) after Cryopreservation and Mesometrial Autotransplantation of Rabbit Ovarian Tissue.

Growth and maturation of follicles and oocytes following xenotransplantation of porcine ovarian tissues and in vitro maturation

Recovery of functional oocytes from cultured premeiotic germ cells after kidney capsule transplantation.

Fertility restore of allotransplantation of vitrified-warmed junvenile ovaries treated with a modified vitrification solution

Follicle culture after ovarian cryostorage

Maturation of mouse primordial follicles by combination of grafting and in vitro culture

Development of antral follicles in cryopreserved cat ovarian tissue transplanted to immunodeficient mice

Human Ovarian Cortex Cryopreservation and Banking

Research on the In Vitro Maturation and Vitrification of Oocytes from Human Luteal Phase